Reflect Scientific Inc (RSCF) Return on Investment ROI from the third quarter of 2024 to third quarter of 2023 and for the year 2024, average high and low, overall ranking from Sep 30 2024 to Sep 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Reflect Scientific Inc  (RSCF)


Reflect Scientific Inc's ROI from its third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Reflect Scientific Inc's ROI in the third quarter of 2024?
Reflect Scientific Inc achieved a return on average invested assets (ROI) of 14.52 % in its third quarter of 2024, which is below Reflect Scientific Inc's average return on investment, which stands at 27.8%.

ROI has improved compared to 13.25% in the second quarter of 2024, due to net income growth.

Within the Healthcare sector 72 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2024 from 0 to 2563.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Investment Change TTM -5.19 % -5.32 % -12.03 % -13.25 % -8.8 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 2 2 2 2 2
Return On Investment (TTM) 14.52 % 13.25 % -0.69 % -6.24 % -13.97 %
RSCF's Overall Ranking # 2563 # 0 # 3069 # 3274 #
Seq. Investment Change TTM -0.88 % 1.57 % -1.61 % -4.29 % -1.02 %
Seq. Net Income Change TTM 8.58 % - - - -
Net Income (TTM) in Millions 0 0 0 0 0

RSCF Company Profile >> Back to RSCF Roi Comparisons >> See Annual RSCF Return On Investment



Return On Investment RSCF's Ranking
Within: No.
Industry # 3
Sector # 73
Overall # 2563

Return On Investment Statistics
High Average Low
1113.45 %
27.8 %
-122.03 %
(Sep 30 2015)   (Sep 30 2018)







Financial Statements
Reflect Scientific Inc's III. Quarter Investments $ 2 Millions RSCF's Balance sheet
Reflect Scientific Inc's III. Quarter Income $ 0 Millions Quarterly RSCF's Income Statement
RSCF's Income by Division See RSCF's Income by Division


RSCF Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 2 2 2 1 1
Y / Y Investment Growth -16.26 % 2.66 % 295.55 % 7.19 % 15.85 %
Net Income in Millions 0 0 1 0 0
Y / Y Net Income Growth - -90.48 % - - -
Annual Return On Investment -23.87 % 3.89 % 41.98 % -34.58 % -47.29 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RSCF's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RSCF's Competitors
Subscribers only: Roi for Reflect Scientific Inc's Suppliers
Subscribers only: Return On Investment for RSCF's Customers

Other Ratios
RSCF's Roa RSCF's Inventory Turnover Ratio RSCF's Growth Rates RSCF's Dividend Statistics
RSCF's Profitability Ratios RSCF's Asset Turnover Ratio RSCF's Dividend Growth
RSCF's Roe RSCF's Valuation Ratios RSCF's Financial Strength Ratios RSCF's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2024, within Healthcare Sector ROI
Mettler toledo International Inc   37.76 %
Idexx Laboratories Inc  36.53 %
Medpace Holdings Inc   35.86 %
Tg Therapeutics Inc   34.74 %
Protagonist Therapeutics inc   33.20 %
Pharmacyte Biotech Inc   32.94 %
Entrada Therapeutics Inc   32.63 %
Nrc Health  32.53 %
Lantheus Holdings Inc   28.51 %
Hims and Hers Health Inc   26.49 %
Carlisle Companies Incorporated  25.77 %
Catalyst Pharmaceuticals Inc   25.48 %
Engene Therapeutics Inc   24.54 %
Corcept Therapeutics Inc  24.03 %
Iradimed Corporation  23.21 %
Acadia Pharmaceuticals Inc   23.07 %
Adma Biologics Inc   22.50 %
Sbc Medical Group Holdings Incorporated  22.33 %
Halozyme Therapeutics Inc   21.88 %
Semler Scientific inc   20.31 %
Alkermes Plc   19.98 %
Eli Lilly And Company  19.83 %
Puma Biotechnology Inc   19.76 %
Kewaunee Scientific Corporation  19.62 %
Chemed Corporation  19.47 %
Zoetis Inc   19.14 %
United Therapeutics Corporation  18.37 %
Filana Therapeutics Inc   18.28 %
Insulet Corporation  18.21 %
Sensus Healthcare Inc   17.83 %

Date modified: 2026-08-31T16:33:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.